Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Process-for-integration-of-a-chosen-gene-on-the-chromosome-of-a-bacterium-using-Mu-transposons

 Multigene vectors
The present invention provides a method for preparing HSV vectors. The method comprises co-...


 Composition and method for inhibiting platelet aggregation
OF THE INVENTION This invention is provides a method of preventing or treating diseases or ...


 Nucleic acid probes
OF THE INVENTION "Derivatizable" nucleotides are nucleotides modified so as to include at the 4-...


 Assay for antiviral activity using complex of herpesvirus origin of replication and cellular protein
The drawings are first described. FIG. 1 is a diagram of the HSV-1 genome and oriS. FIG. 1A ...


 Substrate for detection of mammalian 5-C-DNA methyltransferase
OF THE INVENTION "Oligomeric DNA" or ODN, as used herein, means a DNA having from 10 to 75 "purine ...


 Vinyl ethers of nucleoside analogs
OF THE INVENTION The compounds of the present invention can exist as optical isomers. Both the ...


 Nucleoside analogs
OF THE INVENTION The compounds of the present invention can exist as optical isomers. Both the ...


 Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof
To accomplish those objectives, the present invention provides hydrophobic muiticomponent heparin ...


 Gas permeable bioreactor and method of use
OF THE PREFERRED EMBODIMENTS Like numbered apparatus elements in FIGS. 1-11 are the same. R...


 Method for treating diseases of the inner ear using adamantane derivatives
OF THE INVENTION As already mentioned, the use of adamantane derivatives is possible or ...


 Process for integration of a chosen gene on the chromosome of a bacterium using Mu transposons

Details
Inventors: Richaud, Fran.cedilla.ois; Jarry, Bruno; Takinami, Koichi; Kurahashi, Osamu; Beyou, Anne;
Assignee: Eurolysine (Paris, FR)
Primary Examiner: Stanton; Brian R.
Assistant Examiner:
Attorney, Agent or Firm: Cooley, Godward, Castro, Huddleson & Tatum

The present invention relates to a process for integration of a chosen gene or of a specific DNA molecule into the chromosome or episome of a bacterium by cloning the gene or DNA molecule into a defective transposon which is then integrated into the chromosomal or episomal DNA of the bacteria. The defective transposon is incapable of transposition autonomously but can be induced to transpose when properly complemented. The complementation to induce transposition can be limited so that the defective transposon produces a specific number of copies and thereafter is stable. The number of copies of the defective transposon produced during the period of transposition can be estimated by the level of expression of a marker gene contained within the defective transposon.

DETAILED DESCRIPTION One aim of the invention is to describe a method for amplifying and stably fixing the copies of chosen genes in a microorganism with more flexibility and more reliability than was hitherto possible.
This aim as well as other objects of the invention, such as are envisaged hereafter, have been accomplished, for example, by providing the Escherichia coli bacterium with a transposable element having a wide host range and derived from the Mu phage, and in which the genes of the transposase cannot be expressed or are deleted.
Such a transposon is a defective transposon.
Under particular reversible genetic conditions which are easy to reproduce for organisms of the same genus or of a different genus, this transposon and the genes which can be introduced into it by genetic engineering technologycan be made to multiply inside the chromosome of the microorganism.
When the particular genetic conditions are removed, the various copies of the transposon remain fixed in a stable manner inside the chromosome.
The present invention relates to a process for integration of a chosen gene or of a specific DNA sequence (inside a bacterium) in a DNA sequence such as a chromosome or an episome, wherein: a) the said chosen gene or the chosen DNA sequence is cloned inside a defective transposon outside the essential parts of the transposon, b) the said transposon is integrated in the DNA sequence inside the bacterium.
More particularly, the process according to the invention is used to amplify the chosen copy number of genes in order to obtain a specific number of copies.
In this case the process according to the invention is a process for integration of a specific number of copies of a chosen gene or of a specific DNA sequence in a DNA sequence such as the chromosome or episome of a bacterium, wherein: a) the said chosen gene or the chosen DNA sequence is cloned inside a transposon outside the essential parts of the transposon, the said transposon being defective, b) the said transposon is integrated in the DNA sequence such as the chromosome or the episome of the said bacterium, c) the said defective transposon is complemented so as to be able to transpose several times and the complementation is then stopped after a specific number of transpositions



Related patents
  Transposon-based transformation vectors
I claim: 1. A vector for inserting an exogenous gene into a chromosome of a eukaryotic cell, comprising: (a) a gene encoding a bacterial transposase; (b) two transposon ...
  Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities
OF THE INVENTION Definitions Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary ...
  Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells
OF THE INVENTION Tc1 belongs to the Tc1/mariner superfamily of transposons found in nematodes, arthropods and chordates (Henikoff 1992; Raddice et al. 1994; Robertson 19...
  DNA-based transposon system for the introduction of nucleic acid into DNA of a cell
OF THE PREFERRED EMBODIMENTS The present invention relates to novel tranposases and the transposon that are used to introduce nucleic acid sequences into the DNA of a ...
  Methods for diagnosing sepsis
The present invention provides a pharmaceutical composition for treating conditions (diseases) mediated by the inflammatory cytokine cascade, comprising an effective ...
  Low aromatics composition
The inventions claimed is: 1. A solvent composition comprising (a) a hydrocarbon component in an amount within the range of 91 99 vol. % of said composition; and (b) an ...
  Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
The present invention describes a covalently-linked complex (CLC) for targeting a defined population of cells, comprising a targeting protein; a cytotoxic agent; and an ...
  Compositions and methods for drug delivery using pH sensitive molecules
We claim: 1. A process for transfecting a nucleic acid into a cell in vivo, comprising: a) attaching a membrane activity inhibitor to a membrane active peptide via a ...
  Chiral peptide nucleic acid monomers and oligomers
What is claimed is: 1. A peptide nucleic acid monomer having the formula: ##STR5## wherein: B is a naturally or non-naturally ocurring nucleobase; n is 0, 1, 2, or 3; ...
  Enzymatic DNA molecules
The present invention thus contemplates a synthetic or engineered (i.e., non-naturally-occurring) catalytic DNA molecule (or enzymatic DNA molecule) capable of cleaving ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved